Clinical Trials

Text Size A A

E-Mail to a Friend






secret  Click to Play Audio


Gynecologic Cancer

 

Carboplatin + Paclitaxel w/wo Bevacizumab After Surgery (GOG 213)
A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel Alone or in Combination With Bevacizumab (NSC #704865, IND #7921) Followed by Bevacizumab and Secondary Cytoreduction Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer

Investigator: Benjamin E. Greer, MD;   Conditions: Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer;    Status: Recruiting;   Study ID: NCT00565851

FDG PET for Advanced Ovarian Cancer (FHCRC-7009)
FDG PET and Biomarkers in Treatment Response in Advanced Ovarian Cancer

Investigator: Dr. Joseph Rajendran;   Conditions: Advanced Ovarian Cancer;    Status: Recruiting

Memory and Thinking Skills Workshop in Improving Cognitive Rehabilitation in Ovarian Cancer Survivors (7750)
Behavioral and Neural Indices of Cognitive Rehabilitation in Ovarian Cancer: A Pilot Study

Investigator: Heidi J. Gray, MD;   Conditions: Ovarian Cancer;    Status: Recruiting;   Study ID: NCT01641068

Radiation Therapy Stage I or Stage II Cervical Cancer Post Surgery (GOG 0263)
Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated With Initial Radical Hysterectomy and Pelvic Lymphadenectomy

Investigator: ;   Conditions: Cervical Cancer;    Status: Recruiting;   Study ID: NCT01101451